| scholarly article | Q13442814 |
| P2093 | author name string | Bhattacharya N | |
| Klotz LH | |||
| Catzavelos GC | |||
| DeBoer G | |||
| Kapusta LR | |||
| Morava-Protzner I | |||
| Slingerland JM | |||
| Tsihlias J | |||
| Zbieranowski I | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 542-548 | |
| P577 | publication date | 1998-02-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma | |
| P478 | volume | 58 |
| Q36334415 | 2',4'-dihydroxychalcone, a flavonoid isolated from Herba oxytropis, suppresses PC-3 human prostate cancer cell growth by induction of apoptosis |
| Q39995807 | 2-methoxyestradiol-induced cell death in osteosarcoma cells is preceded by cell cycle arrest |
| Q35747423 | A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. |
| Q33389796 | A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer |
| Q49229100 | Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. |
| Q33822845 | Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer |
| Q90747767 | Chemopreventive Effects of Licorice and Its Components |
| Q36238230 | Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review |
| Q35745372 | Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases |
| Q36854078 | Cyclin-dependent kinase inhibitor p27Kip1 controls growth and cell cycle progression in human uterine leiomyoma |
| Q45164090 | Cyclin-dependent kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer |
| Q36622949 | Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer |
| Q35060298 | Defining aggressive prostate cancer using a 12-gene model |
| Q24803723 | Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer |
| Q54380317 | Differential expression of Pim-3, c-Myc, and p-p27 proteins in adenocarcinomas of the gastric cardia and distal stomach. |
| Q34729632 | Differential role of beta(1C) and beta(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated protein kinase pathways |
| Q35753378 | Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases |
| Q40324948 | Effect of p27(KIP1) on cell cycle and apoptosis in gastric cancer cells |
| Q39838888 | Effect of p27mt gene on apoptosis of the colorectal cancer cell line Lovo |
| Q36001910 | Epigenetic regulation of prostate cancer |
| Q34505232 | Epigenetics of prostate cancer: beyond DNA methylation |
| Q39802754 | Exogenous p27KIP1 expression induces anti-tumour effects and inhibits the EGFR/PI3K/Akt signalling pathway in PC3 cells |
| Q52114229 | Expression of cyclin-dependent kinase inhibitor p27/Kip1 and AP-1 coactivator p38/Jab1 correlates with differentiation of embryonal rhabdomyosarcoma. |
| Q36308280 | Expression of p21(WAF1) and p53 and polymorphism of p21(WAF1) gene in gastric carcinoma |
| Q36308826 | Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance |
| Q35754612 | Expression of the cell cycle inhibitor p27KIP1 is a new prognostic marker associated with survival in epithelial ovarian tumors |
| Q81390442 | Expression profile and prognostic importance in prostate lesions of the reverse transcriptase component of human telomerase (hTERT) and of cyclin-dependent kinase inhibitor p57 (p57kip2a) |
| Q36299247 | Genetic Association Between CDKN1B rs2066827 Polymorphism and Susceptibility to Cancer |
| Q40622027 | Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer |
| Q39817135 | Is repeat biopsy for isolated high-grade prostatic intraepithelial neoplasia necessary? |
| Q40708373 | Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer |
| Q42126151 | Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis |
| Q33276580 | Molecular staging of prostate cancer in the year 2007. |
| Q36084916 | New insights into the tumor suppression function of P27(kip1) |
| Q33735526 | Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition |
| Q36492027 | Overexpression of p27(KIP1) induced cell cycle arrest in G(1) phase and subsequent apoptosis in HCC-9204 cell line |
| Q36963971 | Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study |
| Q35937130 | Prognostic significance of p21 and p53 expression in gastric cancer |
| Q41899984 | Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis |
| Q42461063 | Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. |
| Q37112738 | Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins |
| Q80242323 | Re: p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy |
| Q35165927 | Relation of overexpression of S phase kinase-associated protein 2 with reduced expression of p27 and PTEN in human gastric carcinoma |
| Q24625558 | Skp2: a novel potential therapeutic target for prostate cancer |
| Q33811487 | Subcellular localization of p27 and prostate cancer recurrence: automated digital microscopy analysis of tissue microarrays |
| Q38757478 | Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline Moiety. |
| Q37904028 | The AR dependent cell cycle: mechanisms and cancer relevance |
| Q24800464 | The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells |
| Q21195244 | The expression of the ubiquitin ligase subunit Cks1 in human breast cancer |
| Q34133633 | The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation |
| Q37188430 | Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222 |
| Q24793291 | Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer |
| Q24811943 | U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3. |
| Q37957896 | Using molecular markers to help predict who will fail after radical prostatectomy |
| Q73349313 | p27 cell-cycle inhibitor is inversely correlated with lymph node metastases in right-sided colon cancer |
| Q35745141 | p27 deregulation in breast cancer: prognostic significance and implications for therapy |
| Q24650994 | p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy |
| Q33835822 | p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma |
| Q74454269 | p27(kip1) and Other Cell-Cycle Protein Expression in Normal and Neoplastic Endocrine Tissues |
| Q34472383 | p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies. |
| Q34688671 | p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803. |
| Q33535200 | p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers |
Search more.